Last updated on June 2014

The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients


Brief description of study

The objective of this study is to evaluate the long term safety and efficacy of once weekly dosing of idurasulfase-beta 0.5mg/kg administered in Hunter Syndrome(Mucopolysaccharidosis II) Patients

Clinical Study Identifier: NCT02044692

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Dong Kyu Jin

Samsung Medical Center
Seoul, Korea, Republic of
  Connect »